Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Med Virol ; 88(3): 461-5, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26252424

RESUMO

The study aimed to estimate the prevalence of Hepatitis B virus (HBV) infection and to describe the HBV virological profiles among Senegalese HIV-1-infected patients. We conducted a retrospective study between 2006 and 2010 among Senegalese HIV-1-infected patients from the antiretroviral therapy cohort. Samples were screened using Determine(®) HBsAg or MONOLISA(®) POC test. The HBsAg positivity status was confirmed by Architect(®) HBsAg. Detection of HBeAg, anti-HBe Ab, and HBV DNA load were done for the HBsAg-positive samples. Then, Anti-HBcAb was tested for the HBsAg-negative samples. Microsoft Excel was used for data collection and statistical analyses were performed using Epi info 3.5.1. Overall, 466 HIV-infected patients were enrolled including 271 women (58.4%), and 193 men (41.6%) with a median age of 39 years (19-74 years). The global prevalence of HIV/HBV coinfection (HBsAg positive) was 8.8% (41/466). For HBsAg positives samples, the prevalence of HBeAg and the anti-HBeAb were, respectively, 24.4 and 69.2% and the median of HBV DNA viral load, for 27 HBsAg-positive samples, was 3.75 log10 copies/ml. The virological profiles were the following: 7, 15, and 5 patients infected, respectively, by a replicative virus, an inactive virus and a probably mutant virus. For HBsAg-negative samples, 83 out of 109 were positive for anti-HBcAb. This study showed a significant decrease of the prevalence of HBV/HIV coinfection between 2004 and 2014 (P = 0.003), which highlighted the performance of the Senegalese HBV vaccine program. However, implementing a systematic quantification of HBV DNA viral load could improve the monitoring of HBV-infected patient.


Assuntos
Biomarcadores/sangue , Coinfecção/epidemiologia , Infecções por HIV/complicações , HIV-1 , Hepatite B/epidemiologia , Prevalência , Adulto , Idoso , DNA Viral , Feminino , Infecções por HIV/tratamento farmacológico , Infecções por HIV/epidemiologia , Hepatite B/complicações , Anticorpos Anti-Hepatite B/sangue , Antígenos de Superfície da Hepatite B/sangue , Antígenos de Superfície da Hepatite B/imunologia , Antígenos E da Hepatite B/sangue , Antígenos E da Hepatite B/imunologia , Vírus da Hepatite B/genética , Vírus da Hepatite B/imunologia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Senegal/epidemiologia , Carga Viral , Adulto Jovem
2.
PLoS Negl Trop Dis ; 18(2): e0011755, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38300955

RESUMO

INTRODUCTION: Senegal is a leprosy low-endemic country with nine villages known to be hyperendemic with a leprosy incidence rate above 1,000 per million inhabitants. We aim to implement a door-to-door screening strategy associated with the administration of a single-dose-rifampicin (SDR) as post-exposure prophylaxis (PEP) to household and social contacts in these villages and to identify spatial clustering and assess the risk of leprosy in population according to the physical distance to the nearest index-case. METHODS: From October/2020 to February/2022 active door-to-door screening for leprosy was conducted in nine villages. Using an open-source application, we recorded screening results, demographic and geographic coordinate's data. Using Poisson model we analysed clustering and estimated risk of contracting leprosy in contacts according to the distance to the nearest new leprosy patient. RESULTS: In nine villages, among 9086 contacts listed, we examined 7115. Among 6554 eligible contacts, 97.8% took SDR. We found 39(0.64%) new leprosy cases among 6,124 examined in six villages. Among new cases, 21(53.8%) were children, 10(25.6%) were multibacillary and 05(12.8%) had grade 2 disability. The prevalent risk ratio and 95% confidence intervale(95%CI) adjusted by village were 4.2(95%CI 1.7-10.1), 0.97(95%CI 0.2-4.4), 0.87(95%CI 0.2-25), 0.89(95%CI 0.3-2.6) and 0.70(95%CI 0.2-2.5) for the contacts living in the same household of an index case, 1-25m, 26-50m, 51-75m and 76-100m compared to those living at more than 100m respectively. We identified nine high prevalent clusters including 27/39(69%) of new cases in 490/7,850(6%) inhabitants, with relative risks of 46.6(p-value = 0.01), and 7.3, 42.8, 8.2, 12.5, 11.4, 23.5, 22.3, and 14.6 (non-significant p-values). CONCLUSIONS: Our strategy has proved the feasibility of active screening for leprosy in contacts and the introduction of PEP for leprosy under programmatic conditions. Only individuals living in the same household as the leprosy patient had a significant risk of contracting leprosy. We documented nine clusters of leprosy that could benefit from tailored control activities while optimizing resources.


Assuntos
Hanseníase , Rifampina , Criança , Humanos , Rifampina/uso terapêutico , Profilaxia Pós-Exposição/métodos , Senegal/epidemiologia , Estudos de Viabilidade , Hanseníase/tratamento farmacológico , Hanseníase/epidemiologia , Hanseníase/prevenção & controle , Prevalência
4.
J Virol Methods ; 229: 12-5, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26706730

RESUMO

In the context of early infant diagnosis (EID) decentralization in sub-Saharan Africa, dried blood spot (DBS) is now widely used for HIV proviral DNA detection in resource-limited settings. A new version of CAP/CTM (version 2) has been introduced, recently by Roche Diagnosis as a new real-time PCR assay to replace previous technologies on qualitative detection of HIV-1 DNA using whole blood and DBS samples. The objective of this study was to evaluate CAP/CTM version 2 compared to CAP/CTM version 1 and Amplicor on DBS. A total of 261 DBS were collected from children aged 4 weeks to 17 months born from HIV-seropositive mothers and tested by the three techniques. CAP/CTM version 2 showed 100% of agreement with Amplicor including 74 positive results and 187 negative results. CAP/CTM version 2 versus CAP/CTM version 1 as well as CAP/CTM version 1 versus Amplicor showed two discordant results giving a sensitivity of 98.6%, specificity of 99.5%, positive predictive value of 98.6% and negative predictive value of 99.5%. The concordance was 99.12% (95% of confidence interval) giving a Kappa coefficient of 0.97 (p<0.001). These findings confirmed the expected good performance of CAP/CTM version 2 for HIV-1 EID.


Assuntos
Sangue/virologia , DNA Viral/análise , Infecções por HIV/diagnóstico , HIV-1/isolamento & purificação , Técnicas de Diagnóstico Molecular/métodos , Reação em Cadeia da Polimerase em Tempo Real/métodos , Manejo de Espécimes/métodos , África Subsaariana , DNA Viral/genética , Dessecação , HIV-1/genética , Humanos , Lactente , Valor Preditivo dos Testes , Sensibilidade e Especificidade , Carga Viral/métodos
5.
Orthod Fr ; 80(4): 379-86, 2009 Dec.
Artigo em Francês | MEDLINE | ID: mdl-19954735

RESUMO

INTRODUCTION: Knowledge of the factors influencing traumatic injuries of the anterior teeth is useful to prevent their occurrence. The aim of this case control study is to test the relationship between intrinsic and extrinsic factors and dental traumatism in adolescents. MATERIALS AND METHODS: Cases are 32 adolescent consulting for dental traumatism at the University Dental Clinic Dakar (Senegal). Control subjects (49) are derived from the same population but were free from any dental traumatism. Logistic regression analyses are performed to identify factors that best predict the occurrence of incisor traumatism. RESULTS: Stepwise logistic regression analysis identifies the angle between upper incisor axis to palatal plane (OR = 1.10; 95% CI; 1.01-1.19) and variables related to lip position as best predictors of incisors traumatism. Insufficient lip coverage in rest position increases eight times the odds of having incisors injury. CONCLUSION: Early orthodontic management of the identified factors may help preventing the occurrence of traumatic incisor injuries.


Assuntos
Incisivo/lesões , Adolescente , Traumatismos em Atletas/etiologia , Estudos de Casos e Controles , Cefalometria , Criança , Escolaridade , Feminino , Previsões , Humanos , Incisivo/anatomia & histologia , Lábio/anatomia & histologia , Masculino , Mandíbula/anatomia & histologia , Maxila/anatomia & histologia , Nariz/anatomia & histologia , Ocupações , Palato/anatomia & histologia , Características de Residência , Fatores de Risco , Sela Túrcica/anatomia & histologia , Senegal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA